GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanopharmaceutics Inc (OTCPK:TGRP) » Definitions » Total Payout Yield %

Nanopharmaceutics (Nanopharmaceutics) Total Payout Yield % : 0.00 (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Nanopharmaceutics Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Nanopharmaceutics's current Total Payout Yield % is 0.00%.


Nanopharmaceutics Total Payout Yield % Historical Data

The historical data trend for Nanopharmaceutics's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanopharmaceutics Total Payout Yield % Chart

Nanopharmaceutics Annual Data
Trend Dec15 Dec16 Dec17
Total Payout Yield %
- - -

Nanopharmaceutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Total Payout Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nanopharmaceutics's Total Payout Yield %

For the Biotechnology subindustry, Nanopharmaceutics's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanopharmaceutics's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanopharmaceutics's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Nanopharmaceutics's Total Payout Yield % falls into.



Nanopharmaceutics Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Nanopharmaceutics's Total Payout Yield % for the fiscal year that ended in Dec. 2017 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 0 + 0) / 48.9987
=0.00%

Nanopharmaceutics's annualized Total Payout Yield % for the quarter that ended in Sep. 2018 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 4 / 233.56047
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanopharmaceutics Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Nanopharmaceutics Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Nanopharmaceutics's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanopharmaceutics (Nanopharmaceutics) Business Description

Traded in Other Exchanges
N/A
Address
14120 NW 126 Terrace, Alachua, FL, USA, 32615
Nanopharmaceutics Inc is a clinical-stage specialty pharmaceutical company. It is engaged in developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. The company's pipeline products include Triapine, Ammonium Tetrathiomolybdate, and Aza-TdC targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3 targeting CNS; and Ramoplanin and NanoDOX.